Hsp-27 expression at diagnosis predicts poor clinical outcome in prostate cancer independent of ETS-gene rearrangement
Open Access
- 25 August 2009
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 101 (7) , 1137-1144
Abstract
This study was performed to test the hypothesis that expression of small heat shock protein Hsp-27 is, at diagnosis, a reliable predictive biomarker of clinically aggressive prostate cancer. A panel of tissue microarrays constructed from a well-characterised cohort of 553 men with conservatively managed prostate cancer was stained immunohistochemically to detect Hsp-27 protein. Hsp-27 expression was compared with a series of pathological and clinical parameters, including outcome. Hsp-27 staining was indicative of higher Gleason score (P7, the presence of Hsp-27 retained its power to independently predict poor clinical outcome (Pχ2 trend=31.4, PP<0.001). These findings suggest that apoptotic and cell-migration pathways modulated by Hsp-27 may contain targets susceptible to the development of biologically appropriate chemotherapeutic agents that are likely to prove effective in treating aggressive prostate cancers.Keywords
This publication has 74 references indexed in Scilit:
- The role of Hsp27 and actin in the regulation of movement in human cancer cells responding to heat shockCell Stress and Chaperones, 2009
- Ki-67 and outcome in clinically localised prostate cancer: analysis of conservatively treated prostate cancer patients from the Trans-Atlantic Prostate Group studyBritish Journal of Cancer, 2009
- ETS rearrangements and prostate cancer initiationNature, 2009
- A myosin motor that selects bundled actin for motilityProceedings of the National Academy of Sciences, 2008
- Heterogeneity and clinical significance of ETV1 translocations in human prostate cancerBritish Journal of Cancer, 2008
- Local Progression among Men with Conservatively Treated Localized Prostate Cancer: Results from the Transatlantic Prostate GroupEuropean Urology, 2008
- Complex patterns of ETS gene alteration arise during cancer development in the human prostateOncogene, 2007
- Duplication of the fusion of TMPRSS2 to ERG sequences identifies fatal human prostate cancerOncogene, 2007
- Long-term outcome among men with conservatively treated localised prostate cancerBritish Journal of Cancer, 2006
- Role of fascin in filopodial protrusionJournal of Cell Biology, 2006